文献速递糖尿病肥胖与代谢综合征

自然选择在2型糖尿病及关联性状跨大陆祖先群体差异中的潜在作用:表型与基因型分歧比较

Assessment of the potential role of natural selection in type 2 diabetes and related traits across human continental ancestry groups: comparison of phenotypic with genotypic divergence.
PubMed 文献 · Diabetologia · 2020-09-04

该横断面研究纳入734名城市样本个体(83名非裔美国人、523名美洲印第安人、128名欧裔美国人),比较2型糖尿病及相关性状的表型分歧指数(PST)与全外显子组常见变异计算的遗传分歧系数(FST)。结果显示PST与FST无显著差异,提示这些性状的群体差异与中性演化预期一致,不支持差异自然选择是解释表型差异的必要因素。

要点

  • 2型糖尿病患病率在美洲印第安人、非裔美国人和欧裔美国人中分别为34.0%、12.4%和10.4%。
  • 所有标记的FST为0.130,糖尿病易感性PST为0.149,差异无统计学意义(p=0.35)。
  • BMI、空腹胰岛素和30分钟胰岛素PST与FST比较均无显著差异。

核心结论

  • 2型糖尿病及相关性状在跨大陆祖先群体间的差异与基于遗传力和遗传距离的中性预期一致。
  • 分析不排除自然选择的适度作用,但不支持差异自然选择是解释这些群体表型差异的必要因素。

研究设计与样本

  • 横断面比较研究,纳入734名城市样本个体,包括83名非裔美国人、523名美洲印第安人和128名欧裔美国人。
  • 参与者非基于糖尿病状态或其他性状招募,且彼此亲缘关系不近于三级亲属。
  • 对761名美洲印第安人(排除近亲前)进行全外显子组测序,获得97,388个常见变异(次要等位基因频率≥5%)。
  • 计算所有标记的共祖系数(FST)作为遗传分歧度量,并基于表型差异和遗传力计算表型分歧指数(PST)。
  • 采用 bootstrap 方法检验 PST = FST 的假设。

主要发现

  • 年龄和性别调整后,2型糖尿病患病率在美洲印第安人、非裔美国人和欧裔美国人中分别为34.0%、12.4%和10.4%(组间差异 p=2.9×10-10)。
  • 平均BMI分别为36.3、33.4和33.0 kg/m2(p=1.9×10-7)。
  • 平均空腹胰岛素分别为63.8、48.4和45.2 pmol/l(p=9.2×10-5),平均30分钟胰岛素分别为559.8、553.5和358.8 pmol/l(p=5.7×10-8)。
  • 所有标记的FST为0.130;年龄和性别调整后糖尿病易感性PST为0.149(与FST差异 p=0.35)。
  • BMI的PST为0.094(p=0.54),空腹胰岛素PST为0.095(p=0.54),30分钟胰岛素PST为0.216(p=0.18)。

关键数值与推荐

  • 2型糖尿病诊断采用75 g口服葡萄糖耐量试验。
  • 在糖耐量正常者(n=434)中,以空腹胰岛素和经30分钟血糖调整的30分钟负荷后胰岛素分别作为胰岛素抵抗和分泌的指标。
  • 常见变异定义为次要等位基因频率≥5%。
  • 在中性演化下预期PST = FST;若性状受差异选择,PST应显著大于FST。

临床怎么用

  • 临床解读2型糖尿病及相关代谢性状的群体差异时,应考虑中性遗传分歧而非默认差异自然选择。
  • 针对不同祖先群体的糖尿病风险差异,可基于遗传力和遗传距离进行中性预期评估。
  • 本研究不支持将差异自然选择作为解释群体间表型差异的必要依据。

局限性

  • 研究为横断面设计,样本来自城市人群,可能限制因果推断和泛化性。
  • 遗传力估计基于美洲印第安人参与者,可能不完全适用于其他祖先群体。
  • 分析未排除自然选择的适度作用,仅提示差异选择非必要解释。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Prevalence of type 2 diabetes differs among human ancestry groups, and many hypotheses invoke differential natural selection to account for these differences. We sought to assess the potential role of differential natural selection across major continental ancestry groups for diabetes and related traits, by comparison of genetic and phenotypic differences. METHODS: This was a cross-sectional comparison among 734 individuals from an urban sample (none of whom was more closely related to another than third-degree relatives), including 83 African Americans, 523 American Indians and 128 European Americans. Participants were not recruited based on diabetes status or other traits. BMI was calculated, and diabetes was diagnosed by a 75 g oral glucose tolerance test. In those with normal glucose tolerance (n = 434), fasting insulin and 30 min post-load insulin, adjusted for 30 min glucose, were taken as measures of insulin resistance and secretion, respectively. Whole exome sequencing was performed, resulting in 97,388 common (minor allele frequency ≥ 5%) variants; the coancestry coefficient (FST) was calculated across all markers as a measure of genetic divergence among ancestry groups. The phenotypic divergence index (PST) was also calculated from the phenotypic differences and heritability (which was estimated from genetic relatedness calculated empirically across all markers in 761 American Indian participants prior to the exclusion of close relatives). Under evolutionary neutrality, the expectation is PST = FST, while for traits under differential selection PST is expected to be significantly greater than FST. A bootstrap procedure was used to test the hypothesis PST = FST. RESULTS: With adjustment for age and sex, prevalence of type 2 diabetes was 34.0% in American Indians, 12.4% in African Americans and 10.4% in European Americans (p = 2.9 × 10-10 for difference among groups). Mean BMI was 36.3, 33.4 and 33.0 kg/m2, respectively (p = 1.9 × 10-7). Mean fasting insulin was 63.8, 48.4 and 45.2 pmol/l (p = 9.2 × 10-5), while mean 30 min insulin was 559.8, 553.5 and 358.8 pmol/l, respectively (p = 5.7 × 10-8). FST across all markers was 0.130, while PST for liability to diabetes, adjusted for age and sex, was 0.149 (p = 0.35 for difference with FST). PST was 0.094 for BMI (p = 0.54), 0.095 for fasting insulin (p = 0.54) and 0.216 (p = 0.18) for 30 min insulin. For type 2 diabetes and BMI, the maximum divergence between populations was observed between American Indians and European Americans (PST-MAX = 0.22, p = 0.37, and PST-MAX = 0.14, p = 0.61), which suggests that a relatively modest 22% or 14% of the genetic variance, respectively, can potentially be explained by differential selection (assuming the absence of neutral drift). CONCLUSIONS/INTERPRETATION: These analyses suggest that while type 2 diabetes and related traits differ significantly among continental ancestry groups, the differences are consistent with neutral expectations based on heritability and genetic distances. While these analyses do not exclude a modest role for natural selection, they do not support the hypothesis that differential natural selection is necessary to explain the phenotypic differences among these ancestry groups. Graphical abstract.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Hanson RL, Van Hout CV, Hsueh WC, et al. Assessment of the potential role of natural selection in type 2 diabetes and related traits across human continental ancestry groups: comparison of phenotypic with genotypic divergence. Diabetologia. 2020. PMID: 32886191. doi:10.1007/s00125-020-05272-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。